Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 13, 2014

View Archived Issues

Research sheds light on HMG-1 expression in MS brain tissue

Oxford BioMedica and Novartis expand LentiVector collaboration

Researchers at Edison Pharmaceuticals disclose new agents for Friedreich's ataxia

New aldehyde compounds disclosed for sickle cell disease and other disorders

Chinese group patents new ALK inhibitors for cancer

Novel viral entry inhibitors synthesized for DENV infection

Merck & Co. divulges new JAK inhibitors

First-in-human results for BI-655066 in psoriasis

Omniox receives Wellcome Trust grant to develop oxygen carrier OMX-4.80 for cancer

Ebola vaccine studied in healthcare workers in Mali

BCX-4161 shows efficacy and safety in OPuS-1 trial

Deciphera receives orphan drug designation for gastrointestinal stromal tumor agent

Novel platelet protein biochip used to identify AD biomarkers

FDA approves Harvoni for hepatitis C

FDA approves netupitant/palonosetron combination for CINV

World Thrombosis Day: Advocating for more effective prevention, diagnosis and treatment options

Prosensa starts rolling NDA submission for drisapersen

Endo to acquire Auxilium Pharmaceuticals

Biotron reports promising data from phase II trial of BIT-225 in HCV

FDA approves Bard's paclitaxel-coated angioplasty balloon

Galecto Biotech initiates phase I/II trial of galectin-3 inhibitor for IPF

Biogen Idec files MAA for Elocta in Europe

Impax signs definitive agreement to acquire Tower Holdings and Lineage Therapeutics

Reata starts trial of RTA-408 and ipilimumab in melanoma

Orexo applies to FDA to expand Zubsolv label to include initiation of opioid dependence therapy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...